Literature DB >> 20445556

Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis.

Nima Aden1, Anna Nuttall, Xu Shiwen, Patricia de Winter, Andrew Leask, Carol M Black, Christopher P Denton, David J Abraham, Richard J Stratton.   

Abstract

Systemic sclerosis (SSc) is a disorder of systemic and dermal fibrosis of uncertain etiology. Recently, we found that SSc epidermis is abnormal, taking on an activated phenotype observed during wound healing and tissue repair. As epithelial-fibroblast interactions are important during wound repair and in fibrosis in general, we investigated further the phenotype of the SSc epidermis, and tested whether the SSc epidermis provides a pro-fibrotic stimulus to fibroblasts. In this study we show that in SSc epidermis keratinocyte maturation is delayed, and wound-associated keratins 6 and 16 are induced, in both involved and clinically uninvolved skin. Phosphorylation array analysis revealed induction of stress-induced mitogen-activated protein kinase signaling and mesenchymal feedback through hepatocyte growth factor/c-Met in SSc epidermis. SSc epidermal cells maintained with normal fibroblasts in three-dimensional co-culture were found to stimulate fibroblasts, leading to contractility and connective tissue growth factor expression. These effects depend on elevation of IL-1alpha by the epidermal cells and induction of endothelin-1 and transforming growth factor-beta in fibroblasts. Antagonism of endogenous IL-1alpha using IL-1 receptor antagonist blocked gel contraction by SSc epidermis. We propose that in SSc, epidermal cells are in a persistently activated state and are able to promote dermal fibrosis. These findings are important because biologic therapies could target epithelial-fibroblast interactions in the disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20445556     DOI: 10.1038/jid.2010.120

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  35 in total

Review 1.  Recent developments in myofibroblast biology: paradigms for connective tissue remodeling.

Authors:  Boris Hinz; Sem H Phan; Victor J Thannickal; Marco Prunotto; Alexis Desmoulière; John Varga; Olivier De Wever; Marc Mareel; Giulio Gabbiani
Journal:  Am J Pathol       Date:  2012-03-02       Impact factor: 4.307

Review 2.  Environmental risk factors of systemic sclerosis.

Authors:  Isabelle Marie; Jean-François Gehanno
Journal:  Semin Immunopathol       Date:  2015-07-04       Impact factor: 9.623

3.  Systemic sclerosis disease modification clinical trials design: quo vadis?

Authors:  Fabian A Mendoza; Lynette L Keyes-Elstein; Sergio A Jimenez
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-07       Impact factor: 4.794

4.  Soft tissue fibroblasts from well healing and chronic human wounds show different rates of myofibroblasts in vitro.

Authors:  Florian Schwarz; Martina Jennewein; Monika Bubel; Joerg H Holstein; Tim Pohlemann; Martin Oberringer
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

Review 5.  Targeted therapies for systemic sclerosis.

Authors:  Christopher P Denton; Voon H Ong
Journal:  Nat Rev Rheumatol       Date:  2013-04-09       Impact factor: 20.543

6.  Association of interleukin 1 family with systemic sclerosis.

Authors:  Li Zhang; Jun-Wei Yan; Yu-Jie Wang; Ya-Nan Wan; Bing-Xiang Wang; Jin-Hui Tao; Bing Chen; Bao-Zhu Li; Guo-Jun Yang; Jing Wang
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

Review 7.  Cell-extracellular matrix interactions in normal and diseased skin.

Authors:  Fiona M Watt; Hironobu Fujiwara
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-04-01       Impact factor: 10.005

8.  Elevated serum levels of interleukin-1β and interleukin-33 in patients with systemic sclerosis in Chinese population.

Authors:  Y-J Zhang; Q Zhang; G-J Yang; J-H Tao; G-C Wu; X-L Huang; Y Duan; X-P Li; D-Q Ye; J Wang
Journal:  Z Rheumatol       Date:  2018-03       Impact factor: 1.372

Review 9.  Anti-inflammatory panacea? The expanding therapeutics of interleukin-1 blockade.

Authors:  J Michelle Kahlenberg
Journal:  Curr Opin Rheumatol       Date:  2016-05       Impact factor: 5.006

Review 10.  Epithelial-mesenchymal transition in tissue repair and fibrosis.

Authors:  Rivka C Stone; Irena Pastar; Nkemcho Ojeh; Vivien Chen; Sophia Liu; Karen I Garzon; Marjana Tomic-Canic
Journal:  Cell Tissue Res       Date:  2016-07-27       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.